Named on one round in the feed.
Since 2026-07-07
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
FORE Biotherapeutics A cancer therapeutics company developing targeted treatments for hard-to-treat tumours | Series D+ ext. Published on thinner evidence, 3 sources | n/a | 2026-07-07 | [ PART ] |